Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In situ study of minimal gap size and chlorhexidine for secondary caries development
NL-OMON44491Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chlorhexidine in carious lesion and secondary caries (CARS) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Lesion depth of secondary caries wall lesions and Mineral loss of secondary caries wall lesions. Started Nov 2016; status: active, not recruiting.
02
Drugs
chlorhexidine
03
Conditions
carious lesionsecondary caries (CARS)
Beyond the preview
Go deeper on NL-OMON44491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44491.